Author:
Tsukamoto Jessica Sayuri,Belotto de Oliveira Marcos,D'Alpino Peixoto Renata
Abstract
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal (IP) chemotherapy (HIPEC) is believed to improve outcomes in well-selected patients with peritoneal carcinomatosis. However, morbidity and mortality rates associated with this procedure are substantial. Here, we describe the case of a previously healthy young man who underwent CRS with hyperthermic IP oxaliplatin and developed one episode of tonic-clonic seizure on the second postoperative day.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?;European Journal of Surgical Oncology;2019-03
2. Management of Complications of CRS and HIPEC;Management of Peritoneal Metastases- Cytoreductive Surgery, HIPEC and Beyond;2017-11-30
3. Oxaliplatin;Reactions Weekly;2016-11